Hypothyroid Disorders in Obs & Gynae – Case based approach – Part -1 Lifecare Centre
Hypothyroid Disorders in Obs & Gynae – Case based approach – Part -1
Moderator - Dr Meenakshi Sharma
& Dr Puja Dewan
Panelist
Dr Dipti Nabh
Dr Richa Singhal
Dr Manju Sharma
Dr Deepa Gupta
Dr Renu Chawla
Dr Anita Agarwal
A normal pregnancy results in a number of important reversible physiological and hormonal changes that alter thyroid structure and more importantly function.
Understanding these change are important to interpreting, identifying and managing of thyroid disease in pregnancy.
Thyroid disease in_pregnancy
Presented by: Dr. Ahmad mukhtar
M.B.B.Ch., M.Sc Obstetrics and GynecologyAssistante lecturer of Obstetrics and Gynecology
Faculty of Medicine, Zagazig University
Hypothyroid Disorders in Obs & Gynae – Case based approach – Part -1 Lifecare Centre
Hypothyroid Disorders in Obs & Gynae – Case based approach – Part -1
Moderator - Dr Meenakshi Sharma
& Dr Puja Dewan
Panelist
Dr Dipti Nabh
Dr Richa Singhal
Dr Manju Sharma
Dr Deepa Gupta
Dr Renu Chawla
Dr Anita Agarwal
A normal pregnancy results in a number of important reversible physiological and hormonal changes that alter thyroid structure and more importantly function.
Understanding these change are important to interpreting, identifying and managing of thyroid disease in pregnancy.
Thyroid disease in_pregnancy
Presented by: Dr. Ahmad mukhtar
M.B.B.Ch., M.Sc Obstetrics and GynecologyAssistante lecturer of Obstetrics and Gynecology
Faculty of Medicine, Zagazig University
Hypothyroidism in pregnancy by DR ALKA MUKHERJEE DR APURVA MUKHERJEE NAGPUR M.S.alka mukherjee
Pregnancy is a period that places great physiological stress on both the mother and the fetus. When pregnancy is compounded by endocrine disorders such as hypothyroidism, the potential for maternal and fetal adverse outcomes can be immense. While a lot of attention has been focused on the adverse fetal outcomes consequent to hypothyroidism, attention is also being gradually directed towards the adverse maternal outcomes of this disorder. Role of antibody positivity in influencing outcomes in a euthyroid woman, also needs further clarification. Prompt diagnosis and treatment of hypothyroidism in pregnancy is very essential. Subclinical hypothyroidism also needs to be detected and treated to prevent adverse outcomes, especially maternal. Since women with hypothyroidism during pregnancy, especially of the autoimmune variety might have a flare up of the disorder post-partum, or might continue to require thyroxine replacement post-partum, adequate follow-up is mandatory. While targeted case finding is generally practised, recent evidence seems to indicate that universal screening might be a better option. In conclusion, routine screening, early confirmation of diagnosis and prompt treatment. Allied with regular post-partum follow up, is required to ensure favourable maternal and fetal outcomes.
Thyroid physiology is perceptibly modified during normal pregnancy. These alterations take place throughout gestation, help to prepare the maternal thyroid gland to cope with the metabolic demands of pregnancy, are reversible post-partum and the interpretation of these changes can pose a challenge to the treating physician.
Thyroid disorders are common in pregnancy . This is potential treatable cause of bad obstetric history .Hypothyroidism and hyperthyroidism both should be screened for clinically as well as by laboratory tests .
Due to availability of Thyroid testing ,it is more easily diagnosed and Treated.
Hypothyroid mother if not adequately treated ,there is poor mental development of the baby.
Due to awareness more and more diagnosis is made .There should be universal screening for thyroidal illness in pregnancy .
Hypothyroidism in pregnancy by DR ALKA MUKHERJEE DR APURVA MUKHERJEE NAGPUR M.S.alka mukherjee
Pregnancy is a period that places great physiological stress on both the mother and the fetus. When pregnancy is compounded by endocrine disorders such as hypothyroidism, the potential for maternal and fetal adverse outcomes can be immense. While a lot of attention has been focused on the adverse fetal outcomes consequent to hypothyroidism, attention is also being gradually directed towards the adverse maternal outcomes of this disorder. Role of antibody positivity in influencing outcomes in a euthyroid woman, also needs further clarification. Prompt diagnosis and treatment of hypothyroidism in pregnancy is very essential. Subclinical hypothyroidism also needs to be detected and treated to prevent adverse outcomes, especially maternal. Since women with hypothyroidism during pregnancy, especially of the autoimmune variety might have a flare up of the disorder post-partum, or might continue to require thyroxine replacement post-partum, adequate follow-up is mandatory. While targeted case finding is generally practised, recent evidence seems to indicate that universal screening might be a better option. In conclusion, routine screening, early confirmation of diagnosis and prompt treatment. Allied with regular post-partum follow up, is required to ensure favourable maternal and fetal outcomes.
Thyroid physiology is perceptibly modified during normal pregnancy. These alterations take place throughout gestation, help to prepare the maternal thyroid gland to cope with the metabolic demands of pregnancy, are reversible post-partum and the interpretation of these changes can pose a challenge to the treating physician.
Thyroid disorders are common in pregnancy . This is potential treatable cause of bad obstetric history .Hypothyroidism and hyperthyroidism both should be screened for clinically as well as by laboratory tests .
Due to availability of Thyroid testing ,it is more easily diagnosed and Treated.
Hypothyroid mother if not adequately treated ,there is poor mental development of the baby.
Due to awareness more and more diagnosis is made .There should be universal screening for thyroidal illness in pregnancy .
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Hypothyroidism is a condition marked by an underactive thyroid gland and may be present during pregnancy. It incidence
0.05% of pregnant women
31% positive for TPO Ab
Associated with Gest Hypertension.
Hyperthyroidism in pregnancy:
Hyperthyroidism is characterized by high level of serum thyroxine and triiodothyronine, low levels of thyroid-stimulating hormones.
Hyperthyroidism during pregnancy usually is caused by an
Autoimmune disorder called Grave’s disease. It incidence :-
- 0.2% of pregnant women
- 95% Grave’s disease
It is a presentation on Thyroid Disorder in Pregnancy 2023
Thyroid Disorder:
Thyroid disease is the second most common endocrine disorder affecting women of reproductive age, and when untreated during pregnancy is associated with an increased risk of miscarriage, placental abruption, hypertensive disorders, and growth restriction.
Types of thyroid disorder incidence in pregnancy:
1. Hypothyroidism 0.05%
2. Hyperthyroidism 0.05-0.2%
3. Postpartum thyroiditis 5-10%
Signs:
Hair loss
Sweating
Irritability
Bulging eyes
Rapid heart beat
Nervousness
Tremor of fingers
Difficulty sleeping
Weight loss
Over the past several years it has been proved that maternal thyroid disorder influence the outcome of mother and fetus, during and also after pregnancy. The most frequent thyroid disorder in pregnancy is maternal hypothyroidism. It is associated with fetal loss, placental abruptions, pre-eclampsia, preterm delivery and reduced intellectual function in the offspring.1 In pregnancy, overt hypothyroidism is seen in 0.2% cases2 and sub clinical hypothyroidism in 2.3% cases3. Fetal loss, fetal growth restriction, pre-eclampsia and preterm delivery are the usual complications of overt hyperthyroidism (low TSH and high T3, T4) seen in 2 of 1000 pregnancies whereas mild or sub clinical hyperthyroidism (suppressed TSH alone) is seen in
1.7% of pregnancies and not associated with adverse outcomes4. Autoimmune positive euthyroid pregnancy shows doubling of incidence of miscarriage and preterm delivery. Worldwide more than 20 million people develop neurological sequel due to intra uterine, iodine deprivation5. Other problems of thyroid disorders in pregnancy are post partum thyroiditis, thyroid nodules and cancer, hyper emesis gravidarum etc. Debates and disputes persist regarding several protocol and management plan in this specific spectrum of diseases.
Thyroid Disorders in Obs & Gynae - Case based approach onHyperthyroidism & T...Lifecare Centre
Thyroid Disorders in Obs & Gynae - Case based approach onHyperthyroidism & Thyroid Cancer--- Part 2
Moderator - Dr Meenakshi Sharma
& Dr Puja Dewan
Panelist
Dr Dipti Nabh
Dr Richa Singhal
Dr Manju Sharma
Dr Deepa Gupta
Dr Renu Chawla
Dr Anita Agarwal
Similar to HYPOTHYROIDISM IN PREGNACY:COMMON DILEMMAS, Dr. Jyoti Bhaskar (20)
The Newer Concepts In Endometriosis Management : Dr Sharda JainLifecare Centre
The Newer Concepts In
Endometriosis Management
ENDOMETRIOSIS IS ENIGMA
DIAGNOSTIC DELEMMA
DEBILITATING DISEASE QOL
PROGRESSIVE DISEASE
RECURRENCE IS BIG PROBLEM
NO FINAL VERDICT ON CAUSE
NO PERMANENT CURE
The exact prevalence of endometriosis is unknown, but estimates 10% in the general female population in India but up to 50% in infertile women
The Newer Concepts forReduced Surgery to preserve fertility in Endometrios...Lifecare Centre
The Newer Concepts forReduced Surgery to preserve fertility in Endometriosis
ENDOMETRIOSIS IS ENIGMA
DIAGNOSTIC DILEMMA
DEBILITATING DISEASE QOL
PROGRESSIVE DISEASE
RECURRENCE IS BIG PROBLEM
NO FINAL VERDICT ON CAUSE
NO PERMANENT CURE
The exact prevalence of endometriosis is unknown, but estimates 10% in the general female population in India but up to 50% in infertile women
Anemia Free India Gynaecologist to focuss on *12gm Haemoglobin at Delivery I...Lifecare Centre
Important Highlights
Prophylactic Iron and Folic Acid Supplementation in all six target age groups.
Intensified year-round Behaviour Change Communication (BCC) Campaign for:(a) improving compliance to IFA and deworming, (b) enhancing appropriate infant and young child feeding practices, (c) encouraging increase in intake of iron-rich food through diet and/or fortified foods (d) ensuring delayed cord clamping .
Testing and treatment of anaemia, using digital methods and point of care treatment, with special focus on pregnant women and school-going adolescents.
Addressing non-nutritional causes of anaemia
in endemic pockets with special focus on malaria, hemoglobinopathies and fluorosis
Strategies for Improving Success Rates in ART PARTLifecare Centre
Strategies for Improving Success Rates in ART
Part - 2
Strategies for Improving Success Rates in ART
Tailoring Controlled Ovarian Stimulation
Strategies for Luteal Phase in ART cycles
Endometrial Receptivity Array
How to optimize success rates in ART? : Dr Sharda JainLifecare Centre
How to optimize success rates in ART? : Dr Sharda Jain
How to improve success rates in ART?
The big debate कार्य में आनंद
Evolution of In-vitro Fertilization (IVF)
Factors Influencing IVF Success Ist Part
Strategies for Improving Success Rates in ART Second Part
Innovations & Breakthroughs in IVF Part Three
OPEN DEBATE
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda JainLifecare Centre
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda Jain
Introduction
Social egg freezing (oocyte cryopreservation for non-medical reasons) has evolved as a proactive option for women looking to extend their reproductive possibilities past their peak childbearing years
It is the process of saving or protecting eggs, or reproductive tissues so that a person can use them to have biological children in future
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. Dr. Sharda Jain / Dr Jyoti Agarwal
Life Care Centre has a over 200 ppt on shildeshare.net
For benefit of Medical fraternity.
use it yourself & share among your friends
3. HYPOTHYROIDISM
Most common thyroid disorder in pregnancy
• Overt hypothyroidism : 0.3% to 0.5%
• Subclinical hypothyroidism : 2% to 7%
( In our clinical practise – 1 : 5)
• Anti TPO antibodies are present in 50% of SCH
4. Should women
routinely be screened
for thyroid disease?
YES !
• ALL WOMEN WHO ARE INFERTILE
• Planning Pregnancy, Rec. Miscarriage
• AT FIRST ANTENATAL VISIT OR AT TIME
OF DIAGNOSIS OF PREGNANCY
5. Morbidity Associated with Hypothyroidi
During Pregnancy:
• Spontaneous miscarriages
• Gestational hypertension and preeclampsia
• Premature delivery
• Increased frequency of neonatal ICU admissions
• Increased fetal mortality
• Impaired neuropsychological development
6. Joint Statement of AACE,
ATA and Endocrine Society:
Potential benefits of early detection and treatment
of thyroid dysfunction outweigh the potential side
effects that could result from early detection and
therapy…. Therefore, we favor screening for
subclinical thyroid dysfunction in adults, including
pregnant women and those contemplating
pregnancy.
Thyroid, January, 2005
7. What are the
Screening tests
to be done?
TSH
f T4 and anti TPO
IF HIGH ( Pregnancy specific levels)
8. THYROID PHYSIOLOGY
IN PREGNANCY
Increased oestrogen in
pregnancy
Two- to threefold
increase in TBG
Decrease Free T3
and T4
Similar structure of
hCG and TSH
hCG stimulates
release of T3 and T4
Transient TSH
decrease in weeks 8
to 14
Increased
peripheral
metabolism of T3
and T4
Decrease
Free T3 and T4
9. Thyroid hormone
changes during pregnancy
First trimester
Second
trimester
Third
trimester
TSH
Normal or
decreased
Normal Normal
Free T4 Normal Normal Normal
Free T3 Normal Normal Normal
Total T4 High High High
Total T3 High High High
10. TSH reference value
in pregnancy
Outcome-based recommendations suggest TSH:
• <2.5 in the first and second trimesters
• <3.0 in the third trimester.1,2
1. Marwaha RK, et al. BJOG. 2008;115(5):602-606.
2. Lazarus JH. Br Med Bull. 2010;1-12.
11. Anti TPO
• Over 50% of cases of SCH have anti TPO
• It is Positive only when levels are TWO times
the Normal
• Once positive – should not be repeated again.
12. Anti TPO
Significance :
1. It defines the cause as Autoimmune
2. It cautions for increased chances of PPT
3. Normal TSH with positive antibodies are
prone to become hypothyroid – Need
Monitoring
13. What is the management and appropriate
thyroid hormone replacement
in pregnant women?
15. Subclinical
Hypothyroidism
• L-Thyroxine therapy for all pregnant women
with subclinical hypothyroidism
• Initiate dose according to TSH Levels
AIM: Step up and then Down
• Check TSH level and fT4 after 2-4weeks and
then TSH - 4-6 weeks or every trimester
• Dose to be reduced gradually after delivery
• Repeat TSH at 6 weeks postpartum
17. Overt Hypothyroidism
• Full replacement L-Thyroxine dosage:
– Pregnant women: 2.0 to 2.4 μg/kg of body weight
per day due to increased requirements
• L-Thyroxine treatment to be initiated at a dose of
100 to 150 μg/d
• Step Up and then Step Down
• Follow-up every 6-8 weeks, once TSH is normalised
19. Hypothyroidism
in pregnancy
• Preconception: Optimise therapy in patients with
pre-existing disease
Adjust T4 rx to serum TSH<2.0 prior to pregnancy
• Pregnancy confirmed: Increase dose by 30% to 50%
of preconception dose
• Target levels of TSH:
– <2.5 mIU/L in the first trimester
– <3 mIU/L in later pregnancy
1. Lazarus JH. Br Med Bull. 2010;1-12.
20. • After delivery: Reduce dose gradually to
preconception dose
• Assess thyroid function at 6 weeks postpartum
21. Thyroxin treatment for
hypothyroidism in pregnancy
TSH Average increment in L-Thyroxine dosage in women
without residual functional thyroid tissue depends on the
initial elevation of serum
1. The endocrine society website. http://www.endo-society.org/guidelines/final/upload/Clinical-Guideline-
Management-of-Thyroid-Dysfunction-during-Pregnancy-Postpartum.pdf. Accessed February 27, 2012.
Serum TSH elevation Augmented dose of L-
Thyroxine
5–10 mIU/L 25–50 mg/d
10 and 20 mIU/L 50–75 mg/d
>20 mIU/L 75–100 mg/d
22. EUTHYROID WITH ANTIBODIES
• No replacement with LT4 required
• No role of immunosuppressant
• Monitor the patient with TSH in every
trimester
23. Case study
• A 28-year-old lady with a history of primary
hypothyroidism presented with amenorrhoea for 6
weeks
• Past history: Diagnosed with hypothyroidism about 6
years ago and was started on L-Thyroxine
• She has been taking a stable dose of L-Thyroxine 75
µg/d for the past 2 years
• On examination: Diffuse and nontender enlargement
of thyroid gland was observed
24. Case study
• Laboratory investigations:
• Results of TFT
– TSH: 10.75 mU/L
– FT3: 5 pmol/L
– FT4: 12 pmol/L
• Urine pregnancy test: Positive
Diagnosis: Pregnancy at 6 weeks of gestation
with subclinical hypothyroidism
25. Question
What is the next step in the management of
hypothyroidism in this patient?
1.Maintain the same dose of L-Thyroxine
2.Increase the dose of L-Thyroxine
3.Terminate L-Thyroxine
26. Case study
• Thyroid function tests after 4 weeks:
– TSH: 2.4 mu/L
– FT3: 5 pmol/L
– FT4: 16 pmol/L
• Treatment:
– L-Thyroxine dose was maintained at 100 µg/d
• Advice: Follow up ?
27. Learning Activity
Women with hypothyroidism carry an increased risk of
A. Infertility
B. Miscarriage/spontaneous abortion
C. Maternal hypertension
D. All of the above
29. • Do not change brands
• It has to be taken empty stomach
• Keep it in cool, dry place, away from sunlight
• Minimum gap of 3-4 hrs between LT4 and Iron
and Calcium supplements
LT4 INTAKE
30. Endocrine Society, ATA, AACE
“Best Physician Practices” Guidelines:
• Patients should be maintained on the same
brand name l-thyroxine product
• Change from one brand to another, change
from a brand to a generic product, or change
from one generic to another generic requires
repeat TSH testing in 6-8 weeks
• Small differences in l-thyroxine doses may
have significant adverse clinical outcomes
31. BLOOD TESTS
• TSH CAN BE DONE AT ANYTIME OF THE DAY
• Among thyroid hormones , ask only for
FREE T4
• IF fT4 has to be done for monitoring, Sample
to be collected before taking tablets
• Only anti body to be tested – anti TPO
32. REMEMBER
• Screen all pregnant patients at very first visit
with TSH
• All women with infertility and who come for pre-
pregnancy counselling – Do TSH
• Target values : <2.5 in first trimester
< 3 in later pregnancy
34. ADDRESS
11 Gagan Vihar, Near
Karkari Morh Flyover,
Delhi - 51
CONTACT US
9650588339
011-22414049
WEBSITE :
www.lifecareivf.in
www.lifecarecentre.in
www.globalstemgenn.com
ISO 14001:2004 (EMS)
…..Caring hearts, healing hands
ISO 9001:2008
Helpline : 9599044257
Web.www.lifecareivf.in
Helpline : 9910081484
Helpline 9599044357
Editor's Notes
Thyroid hormone changes during the course of pregnancy are given in the table.
References:
Thyroid disease and pregnancy. American Thyroid Association website. http://www.thyroid.org/patients/brochures/Thyroid_Dis_Pregnancy_broch.pdf.
Outcome-based recommendations suggest TSH <2.5 in the first and second trimesters and <3.0 in the third trimester.1,2
References:
Marwaha RK, et al. BJOG. 2008;115(5):602-606.
Lazarus JH. Thyroid function in pregnancy. Br Med Bull. 2010;1-12.
The American Association of Clinical Endocrinologist recommends routine TSH assay before pregnancy or in the first trimester. Additional tests include free T4 estimate, thyroid autoantibodies—antithyroid peroxidase and antithyroglobulin autoantibodies, thyroid scan, ultrasonography or both.
L-Thyroxine therapy should be administered to all pregnant women with hypothyroidism even if it is mild. The L-Thyroxine dose must be increased in patients with moderate-to-severe hypothyroidism.
Check TSH level every 6 weeks during pregnancy.
References:
Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of
The AACE recommends high-quality brand of L-Thyroxine for hypothyroidism treatment. Same brand of L-Thyroxine is preferred throughout pregnancy. The mean replacement dosage of L-Thyroxine is 1.6 μg/kg of body weight per day. L-Thyroxine replacement dose may be doubled the estimated final replacement daily dose for initial few days depending on the severity and duration of hypothyroidism and cardiac status of the patient. Once TSH is in the normal range, follow-up after 6 months and thereafter annually is recommended.
References:
Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8(6):457-469.
L-Thyroxine dose during preconception needs to be optimised in patients with pre-existing hypothyroidism in order to avoid infertility issues. On confirmation of pregnancy, the dose of L-Thyroxine should be increased by 30% to 50% of the preconception dose. The TSH levels are checked early in the first trimester and should be aimed at <2.5 mIU/L. During the later stages of pregnancy, the TSH levels should be <3 mIU/L. After delivery, the dose of L-Thyroxine should be reduced to the preconception dose. After 6 weeks of delivery, the thyroid function should be reassessed. Postablative and postsurgical hypothyroidism require higher doses of L-Thyroxine.
References:
Lazarus JH. Thyroid function in pregnancy. Br Med Bull. 2010;1-12.
Average increment in L-Thyroxine dosage in women without residual functional thyroid tissue depends on the initial elevation of serum TSH. The table in the slide illustrates L-Thyroxine dose based on serum TSH elevation.
References:
The endocrine society website. http://www.endo-society.org/guidelines/final/upload/Clinical-Guideline-Management-of-Thyroid-Dysfunction-during-Pregnancy-Postpartum.pdf. Accessed February 27, 2012.
Let us analyse the significance of hypothyroidism in pregnancy through a case study.
A 28-year-old woman with history of primary hypothyroidism presented with amenorrhoea for 6 weeks. She was diagnosed hypothyroid 6 years ago and was on L-Thyroxine. For the past 2 years, she has been taking a stable dose of L-Thyroxine 75 µg/d. On examination, diffuse and nontender enlargement of thyroid gland was observed.
Results of laboratory investigations are mentioned in the slide. Based on these findings, she was diagnosed with pregnancy at 6 weeks with primary hypothyroidism.
Results of thyroid function test after 4 weeks are mentioned in the slide. The patient was advised to continue the same dose of L-Thyroxine therapy, which was 100 µg/d. She was advised periodic TSH evaluation, which is once in each trimester or once every 6 to 8 weeks preferably.